Menu

依普利酮国内能买的到吗

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Can Indian medicine be purchased in China? Currently, eplerenone tablets are only available in the United States and Japan. China has not yet been approved for marketing. Patients who want to purchase this drug must go abroad to purchase it themselves, or find domestic and overseas medical institutions to purchase it. It is understood that the price of the original drug eplerenone in the United States is relatively high. The specifications are 50mg-30 tablets/box, and the price is about 124.09 US dollars. The price is very expensive, and many patients say they cannot afford it. But luckily, there are also generic versions of this product in India, which have the same efficacy and are affordable. According to Medical Travel, we learned that the price of eplerenone 50mg 100 tablets from India's Lupine Pharmaceuticals is about $500. Since exchange rates fluctuate and prices are not fixed, please consult Medical Travel for specific prices.

The new generation of selective aldosterone antagonist (eplerenone) was developed by Pfizer/Pharmacia with the trade name Inspra. It was first launched in the United States in 2002 and applied for patent protection in China in 2006. The combination of eplerenone (Inspra) and enalapril can significantly reduce left ventricular weight, and the addition of hydrochlorothiazide and amlodipine can further reduce it. Previous studies have confirmed that left ventricular mass index is associated with event-free survival. In studies on patients with diabetes mellitus and proteinuria, both eplerenone and enalapril can reduce systolic blood pressure and diastolic blood pressure, but eplerenone reduces the urinary albumin/inosine ratio UACR more significantly than enalapril. It also has a good antihypertensive effect on simple systolic hypertension, and has a good antihypertensive effect on diet-induced obesity-related hypertension. In addition, eplerenone can significantly reduce the ultrafiltration effect of glomeruli and reduce albuminuria in patients with hypertension. This renal protective effect is more obvious for hypertensive patients with diabetes.

Related hot article recommendations: /newsDetail/76392.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。